Virax Biolabs Group Limited Ordinary Shares (VRAX)

NASDAQ HEALTHCARE
$0.14 +0.90% RSI 43 Neutral Add Alert

Moving Averages

SMA 200
$0.50
Price below

Company Profile

Virax Biolabs Group Limited, a biotechnology company, sells, distributes and markets diagnostic test kits and medical technology products and PPE for the prevention, detection, diagnosis and risk management of viral diseases in the field of immunology. The company is headquartered in London, the United Kingdom.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$772,780
P/E Ratio
None
EPS
$-0.94
Beta
1.598
Dividend Yield
0.00%
52-Week High
$1.2
52-Week Low
$0.1

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 57.0
VRTX
Vertex Pharmaceuticals Inc
RSI 41.0
CRSP
CRISPR Therapeutics AG
RSI 50.0
MRNA
Moderna Inc
RSI 36.0
VKTX
Viking Therapeutics Inc
RSI 38.0
SRPT
Sarepta Therapeutics Inc
RSI 51.0

Data last updated: April 11, 2026 at 10:14 AM EDT

Track VRAX for free

Get e-mail RSI alerts when Virax Biolabs Group Limited Ordinary Shares enters oversold or overbought territory. Free forever.

Add Alert